The Contribution of Positron Emission Tomography (Pet) with 18 F-Fluorodeoxyglucose (Fdg) in the Preoperative Detection of Axillary Metastases of Breast Cancer: The Experience of the National Cancer Institute of Milan
Restricted accessResearch articleFirst published online March, 1997
The Contribution of Positron Emission Tomography (Pet) with 18 F-Fluorodeoxyglucose (Fdg) in the Preoperative Detection of Axillary Metastases of Breast Cancer: The Experience of the National Cancer Institute of Milan
DantonD.N.: The role of axillary lymph node dissection in the management of breast cancer. Principles and practice of oncology, 6: 1–16, 1992.
2.
NJH Consensus Conference.Treatment of early stage breast cancer. JAMA, 265: 391–395, 1991.
3.
WahlR.L., CodyR.L., HutchinsG.D., MudgattE.E.: Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[18F]-fluoro-2-deoxy-d-glucose. Radiology, 179: 765–770, 1991.
4.
StraussL.G., ContiP.S.: The application of PET in clinical oncology. J. Nucl. Med., 32: 623–664, 1991.
5.
NielsonY.T., HohC.K., HawkinsR.A., ZinnerM.J., DahebomM., ChoiY., MaddahiJ., BrunicardiF.C., PhelpsM.E., GlapsyJ.A.: The application of positron emission tomographic imaging with fluorodeoxyglucose to the evaluation of breast disease. Ann. Surg., 216(1): 27–34, 1992.
6.
HohC.K., HawkinsR.A., GlaspyJ.A., DahlbomM., TseN.Y., HoffmanE.J., SchiepersC., ChoiY., RegeS., NitzscheE., MaddahiJ., PhelpsE.: Cancer detection with whole-body PET using 2-[18F]-fluoro-2-deoxy-d-glucose. J. Comput. Assist. Tomogr., 17: 582–589, 1993.
7.
AdlerL.P., CroweJ.P., al KaisiN.K., SunshineJ.L.: Evaluation of breast masses and axillary lymph nodes with (F-18)-2-deoxy-2-fluoro-d-glucose PET. Radiology, 187: 743–750, 1993.
8.
PietrzykU., ScheidhauerK., ScharlA., SchichaH.: Presurgical visualization of primary breast carcinoma with PET emission and transmission imaging. J. Nucl. Med., 36: 1882–1884, 1995.
9.
ScheidhauerK., ScarlA., PietrzykU., WagnerR., GohringU.J., SchomackerK., SchicaH.: Qualitative [18F]FDG positron emission tomography in primary breast cancer: clinical relevance and practicability. Eur. J. Nucl. Med., 23: 618–623, 1996.
10.
BombardieriE., CrippaF., MaffioliL., ChitiA., CastellaniM.R., GrecoM., AgrestiR., BogniA., ChiesaC., De SanctisV., MassaronS., PascaliC.: Axillary lymph node metastases detection with nuclear medicine approaches in patients with newly diagnosed breast cancer: can positron emission tomography (PET) with 18F-FDG be cosidered as the best method? Int. J. Oncology, 8: 693–699, 1996.
